Pregnancy
Fosamprenavir (Telzir) has not been tested for safety and efficacy in pregnant women. However, in the clinical trials that led to fosamprenavir’s European approval, five women exposed to the drug during pregnancy delivered healthy babies.
latest aidsmap news
- Higher levels of drug resistance seen after first-line NNRTI failure than boosted PI failure: meta-analysis
- Wide variation found in anal HPV viral loads in HIV-positive men
- Offering rapid point-of-care tests would increase uptake of HIV testing
- Low rate of spontaneous hepatitis C clearance in patients with HIV; early HIV treatment recommended for those with chronic hepatitis C infection
- Cluster of multi-drug resistant HIV transmissions in Seattle
- Hypersensitivity testing for abacavir slightly more cost-effective than tenofovir use, if both drugs equally potent
- HIV no longer bar to granting of US visa for short visits
- Kidney disease risk increased for patients with HIV and hepatitis C
- Nearly one in three UK HIV patients has considered suicide in the previous week
- A new day for health in South Africa: Manto is replaced as health minister by TAC supporter